Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Ferrer

Showing results (141-150 of 221) with videos related to

Pageof 23
Sort By:
Thrombosis Research|July 19, 2014
Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patientsLuis Jara-Palomares, Raquel Sanchez-Oro-Gomez, Teresa Elias-Hernandez, et al.
Anales De Pediatria|October 14, 2021
The impact of "faster aspart" on blood glucose control in children and adolescents with type 1 diabetes treated using a sensor-augmented insulin pumpJesús González de Buitrago Amigo, Ana González García, Paula Díaz Fernández, et al.
Medicina Clinica|December 6, 2011
[Outpatient management of patients with deep vein thrombosis and cancer: a study of safety, cost and budget impact]Luis Jara Palomares, Candela Caballero Eraso, Teresa Elías Hernández, et al.
International Wound Journal|January 14, 2026
Cultural Adaptation and Psychometric Assessment of the Catalan Version of the Wound-QoL-17Marta Casals Zorita, Clara Masó Albareda, Natalia Palacio Arronis, et al.
Enfermeria Clinica|February 24, 2009
[Prevalence of chronic wounds in a county in the province of Barcelona (Spain)]Marta Ferrer-Solà, Emilia Chirveches-Pérez, Gemma Molist-Señé, et al.
Scientific Reports|August 23, 2017
Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cellsEva Serrano-Candelas, Rubén Martínez-Aranguren, Olga Vega, et al.
Journal of Clinical Medicine|August 7, 2019
Cue-Elicited Anxiety and Alcohol Craving as Indicators of the Validity of ALCO-VR Software: A Virtual Reality StudyAlexandra Ghiţă, Olga Hernández-Serrano, Yolanda Fernández-Ruiz, et al.
Journal of Clinical Medicine|March 29, 2023
An Attentional Bias Modification Task, through Virtual Reality and Eye-Tracking Technologies, to Enhance the Treatment of Anorexia NervosaFranck-Alexandre Meschberger-Annweiler, Mariarca Ascione, Bruno Porras-Garcia, et al.
European Journal of Dermatology : EJD|November 1, 2017
Expert opinion: defining response to omalizumab in patients with chronic spontaneous urticariaMarta Ferrer, Isabelle Boccon-Gibod, Margarida Gonçalo, et al.
Health and Quality of Life Outcomes|February 2, 2019
Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)Ignacio Jauregui, Ana Gimenez-Arnau, Joan Bartra, et al.
Pageof 23

Showing results (141-150 of 221) with videos related to

Sort By:
Pageof 23
Thrombosis Research|July 19, 2014
Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patientsLuis Jara-Palomares, Raquel Sanchez-Oro-Gomez, Teresa Elias-Hernandez, et al.
Anales De Pediatria|October 14, 2021
The impact of "faster aspart" on blood glucose control in children and adolescents with type 1 diabetes treated using a sensor-augmented insulin pumpJesús González de Buitrago Amigo, Ana González García, Paula Díaz Fernández, et al.
Medicina Clinica|December 6, 2011
[Outpatient management of patients with deep vein thrombosis and cancer: a study of safety, cost and budget impact]Luis Jara Palomares, Candela Caballero Eraso, Teresa Elías Hernández, et al.
International Wound Journal|January 14, 2026
Cultural Adaptation and Psychometric Assessment of the Catalan Version of the Wound-QoL-17Marta Casals Zorita, Clara Masó Albareda, Natalia Palacio Arronis, et al.
Enfermeria Clinica|February 24, 2009
[Prevalence of chronic wounds in a county in the province of Barcelona (Spain)]Marta Ferrer-Solà, Emilia Chirveches-Pérez, Gemma Molist-Señé, et al.
Scientific Reports|August 23, 2017
Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cellsEva Serrano-Candelas, Rubén Martínez-Aranguren, Olga Vega, et al.
Journal of Clinical Medicine|August 7, 2019
Cue-Elicited Anxiety and Alcohol Craving as Indicators of the Validity of ALCO-VR Software: A Virtual Reality StudyAlexandra Ghiţă, Olga Hernández-Serrano, Yolanda Fernández-Ruiz, et al.
Journal of Clinical Medicine|March 29, 2023
An Attentional Bias Modification Task, through Virtual Reality and Eye-Tracking Technologies, to Enhance the Treatment of Anorexia NervosaFranck-Alexandre Meschberger-Annweiler, Mariarca Ascione, Bruno Porras-Garcia, et al.
European Journal of Dermatology : EJD|November 1, 2017
Expert opinion: defining response to omalizumab in patients with chronic spontaneous urticariaMarta Ferrer, Isabelle Boccon-Gibod, Margarida Gonçalo, et al.
Health and Quality of Life Outcomes|February 2, 2019
Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)Ignacio Jauregui, Ana Gimenez-Arnau, Joan Bartra, et al.
Pageof 23